Contravisory Investment Management, Inc. Gilead Sciences, Inc. Transaction History

Contravisory Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 12, 2023	BUY	$76.01 - $86.7 $351,470 - $400,900	4,624 New	4,624 $356,000
Q1 2019 Apr 08, 2019	SELL	$62.53 - $70.05 $12,506 - $14,010	-200 Closed	0 $0
Q4 2018 Jan 14, 2019	BUY	$60.54 - $79.0 $12,108 - $15,800	200 New	200 $13,000
Q3 2018 Oct 11, 2018	SELL	$71.28 - $78.92 $14,256 - $15,784	-200 Closed	0 $0
Q2 2018 Jul 11, 2018	SELL	$64.88 - $75.68 $9,018 - $10,519	-139 Reduced 41.0%	200 $14,000
Q4 2017 Jan 18, 2018	BUY	$71.15 - $83.52 $9,889 - $11,609	139 Added 69.5%	339 $24,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $14,422 - $17,094	200	200 $16,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.